ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
https://doi.org/10.20996/1819-6446-2014-10-3-283-287
Abstract
Aim. To assess the effect of the 24-week antihypertensive therapy with fixed-dose drug combination (lisinopril plus amlodipine) on endothelial dysfunction and renal function in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2.
Material and methods. 30 hypertensive patients with DM type 2 (aged 40-65 years) were included into the study. Endothelial function (plasma and vascular components) and renal function were studied.
Results. Combined antihypertensive therapy significantly improved parameters of endothelial function in patients with HT and DM type 2: production of nitric oxide (NO) in blood serum and urine increased by 122.8% and 65.8%, respectively. Along with these secretion of endothelin (ET-1) in serum and urine decreased by 26.1% and by 76.1%, respectively, p<0.05. A statistically significant redistribution of patients by type of microcirculation was established: the share of patients with normal type of microcirculation increased by 73.4%. There was a statistically significant reduction of proteinuria and albuminuria by 58% and 43.6%, respectively. The share of patients with chronic kidney disease with an estimated GFR 30-60 ml/min/1.73 m2 decreased by 16.7%.
Conclusions. It has been shown that the prescription of a long-term antihypertensive therapy with dose-fixed combination (lisinopril plus amlodipine) is safe and effective for endothelial function improvement, including renal endothelium, with no negative effect on glucose and lipid metabolism in patients with HT and DM type 2.
About the Authors
M. E. Statsenko
Volgograd State Medical University
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
M. V. Derevyanchenko
Volgograd State Medical University
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
M. N. Titarenko
Volgograd State Medical University
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
O. R. Pastuchova
Volgograd State Medical University
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
Russian Federation
Pavshih Bortsov pl. 1, Volgograd, 400131 Russia
References
1. Dedov II, Shestakova MV, eds. Algorithms of specialized medical care for patients with diabetes. 6th ed. Moscow: Informpoligraf; 2013. Russian (Дедов И. И., Шестакова М. В., редакторы. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 6-е изд. М.: ООО Информполиграф; 2013).
2. Cardiovascular risk and chronic kidney disease: cardio nephroprotection strategy. National Guidelines. Available at: http://scardio.ru/content/Guidelines/nefrorek2013.doc. Accessed by 20.06.2014. Russian (Рабочая группа Российского кардиологического общества, Научного общества нефрологов России, Российской ассоциацией эндокринологов, Российского медицинского общества по артериальной гипертонии, Национального общества по изучению атеросклероза, Российского научного медицинского общества терапевтов. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Национальные рекомендации. Доступно на: http://scardio.ru/content/Guidelines/nefrorek2013.doc. Проверено 20.06.2014).
3. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J 2013; 34: 2159-19.
4. Statsenko ME, Derevyanchenko MV, Ostrovsky OV, et al. Endothelial dysfunction - a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes. Ter Arkh 2013; (9): 57-62. Russian (Стаценко М.Е., Деревянченко М.В., Островский О.В. и др. Дисфункция эндотелия – мишень для комбинированной антигипертензивной терапии у больных артериальной гипертонией с сахарным диабетом 2 типа. Терапевтичекий Архив 2013; (9): 57-62).
5. Garrido A.M., Griendling K.K. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009; 302: 148-58.
6. Makolkin VI, Podzolkov VI, Pavlov VI. Microcirculation in hypertension. Cardiology 2002;(7):36-40. Russian (Маколкин В.И., Подзолков В.И., Павлов В.И. Состояние микроциркуляции при гипертонической болезни. Кардиология 2002; (7): 36-40).
7. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
8. Statsenko ME, Derevyanchenko MV. Features of hypertensive patients with type 2 diabetes: a view of the cardiologist. Pharmateka 2013; 16: 52-7. Russian (Стаценко М.Е., Деревянченко М.В. Особенности ведения пациентов с артериальной гипертензией и сахарным диабетом 2 типа: взгляд кардиолога. Фарматека 2013; 16: 52-7).
Review
For citations:
Statsenko M.E., Derevyanchenko M.V., Titarenko M.N., Pastuchova O.R. ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Rational Pharmacotherapy in Cardiology. 2014;10(3):283-287. (In Russ.) https://doi.org/10.20996/1819-6446-2014-10-3-283-287
Views: 629
Email this article 